LALINDEN ADVISORS LP

Institutional investor · Portfolio as of Q3 2025

SEC EDGAR SourceSEC Filings

Top Holdings407 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
120.6M$546.2M3.6%
Increased
74
122.9M$508.8M3.4%
Increased
65
265.3M$370.2M2.5%
Increased
58
158.9M$356.1M2.4%
Decreased
0
288.5M$343.1M2.3%
New
80
??LI AUTO INCDelisted
Bond
270.2M$309.1M2.1%
Decreased
0
166.4M$305.6M2.0%
Increased
86
136.9M$304.6M2.0%
Increased
61
279.3M$292M1.9%
Increased
49
138.7M$270.3M1.8%
Increased
50
264.6M$270.3M1.8%
Decreased
0
98.3M$239.3M1.6%
Increased
51
??EXACT SCIENCES CORPDelisted
Bond
245M$235.6M1.6%
6 qtrssince 2024-Q2
Increased
61
??EXACT SCIENCES CORPDelisted
Bond
248.1M$230.1M1.5%
7 qtrssince 2024-Q1
Increased
67
??MKS INC.
Bond
208.3M$228.7M1.5%
Decreased
0
89.3M$215.9M1.4%
Increased
64
64.7M$207.6M1.4%
Increased
64
??ASCENDIS PHARMA ADelisted
Bond
144.9M$198M1.3%
Decreased
0
208M$189.3M1.3%
Increased
52
119M$182.4M1.2%
Decreased
0
$15B
AUM
407
Positions
Q3 2025
Filing
Rating · 2.0
Quarterly Portfolio Change
+2%Q3'23$9.7B+8%Q4'23$10.5B+15%Q4'24$12.1B+22%Q1'25$14.7B+10%Q2'25$16.3B-8%Q3'25$15B
Activity profile
$ moved · Q3'25
New17%Increased26%Decreased29%Exited29%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.6 quarters
<1Q26%1-4Q46%1-2Y11%2Y+18%

LINDEN ADVISORS LP manages $15B across 407 positions as of Q3 2025. Top holdings: Bloom Energy Corp (3.6%), BLOOM ENERGY CORP (3.4%), LUMENTUM HLDGS INC (2.5%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q3 2025 Summary

Active quarter - 111 new positions, 80 exits, 51 increased. No standout high-conviction moves this quarter. Portfolio: $15.0B across 407 positions.

Top holdings by portfolio weight

Total AUM$15B
Bloom Energy3.64%
BLOOM ENERGY3.39%
LUMENTUM HLD2.47%
MICROSTRATEG2.37%
JAZZ INVESTM2.29%
LI AUTO INC2.06%
ALIBABA GROU2.04%
PELOTON INTE2.03%
LIBERTY MEDI1.95%
SEMTECH CORP1.80%
Other1.80%

Portfolio allocation by GICS sector

Sectors10
Financial Services68.43%
Unknown22.68%
Technology3.37%
Real Estate1.77%
Industrials1.25%
Consumer Cyclical0.91%
Healthcare0.62%
Basic Materials0.38%
Utilities0.33%
Communication Services0.26%

Behavioral investing profile

Checking access…
Momentum Trader
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record61
Conviction31
Concentration37
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
BR10806XAD4BRIDGEBIO PHARMA INC
Q3 2024 Q2 2026+157.4M shares+$200.5M
7Q
VI928298AR9VISHAY INTERTECHNOLOGY INC
Q4 2024 Q2 2026+353.9M shares+$770.5M
4Q
CO19459JAC8COLLEGIUM PHARMACEUTICAL INC
Q3 2025 Q2 2026+26.6M shares+$50.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used